TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14996698

Group type: EXPERIMENTAL
Intervention: Self taught training package
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Attendance at a training workshop
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Self taught training package and Attendance at a training workshop
Number of subjects: 3
Study: 11493492

Group type: EXPERIMENTAL
Intervention: Model simulation (MF)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Model simulation (MF) after calibration
Number of subjects: 54

Group type: COMPARATOR
Intervention: Thermodilution (TD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Model simulation (MF) during surgery
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Model simulation (MF) with consecutive measurements
Number of subjects: 54
Study: 9764982

Group type: EXPERIMENTAL
Intervention: Alpha-interferon plus ofloxacin (600 mg daily)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Alpha-interferon alone
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Combined therapy (alpha-interferon plus ofloxacin)
Number of subjects: 55
Study: 7844205

Group type: EXPERIMENTAL
Intervention: Low-dose step-down hormone replacement therapy (HRT)
Number of subjects: 0
Study: 3042355

Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 412

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 412

Group type: EXPERIMENTAL
Intervention: Urapidil (combination therapy)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Prazosin (combination therapy)
Number of subjects: 412
Study: 31691370

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Dexamethasone implant
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Phakic patients
Number of subjects: 162
Study: 29945395

Group type: EXPERIMENTAL
Intervention: Huazhuo Jiedu formula, 1 dose/day for 6 months
Number of subjects: 70

Group type: COMPARATOR
Intervention: Alatan Wuwei Wan, bid, 1 bag/time for 6 months
Number of subjects: 70
Study: 27760697

Group type: EXPERIMENTAL
Intervention: Elastic Compression Stocking (ECS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (no ECS)
Number of subjects: 400
Study: 24926629

Group type: EXPERIMENTAL
Intervention: Brain Wave Vibration (BWV) training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (similar yoga exercises without rhythmic components)
Number of subjects: 31
Study: 22828090

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine/HCT 150/5/12.5 mg (week 4)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine/HCT 300/10/25 mg (week 8)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Aliskiren/amlodipine/HCT 150/5/12.5 mg (week 2)
Number of subjects: 1191

Group type: COMPARATOR
Intervention: Dual combinations (aliskiren/amlodipine 150/5 mg, aliskiren/HCT 150/12.5 mg, amlodipine/HCT 5/12.5 mg)
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Triple combination (aliskiren/amlodipine/HCT)
Number of subjects: 1191
Study: 19765266

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Calcineurin inhibitor (Control)
Number of subjects: 252
Study: 18348746

Group type: EXPERIMENTAL
Intervention: r-hFSH (300 IU)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: r-hLH (450 IU)
Number of subjects: 97

Group type: COMPARATOR
Intervention: r-hLH/r-hFSH (fixed combination)
Number of subjects: 97
Study: 15888156

Group type: EXPERIMENTAL
Intervention: 1 x weekly treatment
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 x weekly treatment
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 3 x weekly treatment
Number of subjects: 14
Study: 12698396

Group type: EXPERIMENTAL
Intervention: Heparin-coated extracorporeal circuit
Number of subjects: 88

Group type: COMPARATOR
Intervention: Uncoated extracorporeal circuit
Number of subjects: 88
Study: 10353862

Group type: EXPERIMENTAL
Intervention: Thalidomide 200 mg/day for 4 weeks
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Thalidomide
Number of subjects: 24
Study: 8943671

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (cisplatin 120 mg/m2 and etoposide 100 mg/m2 i.v. for 3 days, every fourth week) followed by radiotherapy (56 Gy to the chest)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Radiotherapy only (56 Gy to the chest)
Number of subjects: 302
Study: 1777371

Group type: EXPERIMENTAL
Intervention: Caffeine (250 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline (250 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7307569

Group type: EXPERIMENTAL
Intervention: Emulsified lanolin and mineral oil bath additive
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual bath soap
Number of subjects: 0
Study: 30665439

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (1000 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 29165598

Group type: EXPERIMENTAL
Intervention: Metformin (2000 mg)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258
Study: 26475347

Group type: EXPERIMENTAL
Intervention: Medical clowning
Number of subjects: 100

Group type: COMPARATOR
Intervention: EMLA (local anesthetic cream)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no clown, no EMLA)
Number of subjects: 100
Study: 24172652

Group type: EXPERIMENTAL
Intervention: Soft contact lens (SCL) applied post-surgery
Number of subjects: 63

Group type: COMPARATOR
Intervention: Antibiotic pomade with bandage (control)
Number of subjects: 63
Study: 23109694

Group type: EXPERIMENTAL
Intervention: Lanreotide (30 mg injection)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lanreotide
Number of subjects: 80
Study: 19022433

Group type: EXPERIMENTAL
Intervention: Blood serum of endometriosis patients
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Postoperative blood serum of endometriosis patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: CA-125
Number of subjects: 59
Study: 17963528

Group type: EXPERIMENTAL
Intervention: Treatment for mild gestational diabetes mellitus (dietary advice, blood glucose monitoring, insulin therapy as needed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine pregnancy care
Number of subjects: 0
Study: 15678734

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.15 microg kg(‐1)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.30 microg kg(‐1)
Number of subjects: 63
Study: 12093058

Group type: EXPERIMENTAL
Intervention: Low dose amiodarone (200 mg/day)
Number of subjects: 392
Study: 9811284

Group type: EXPERIMENTAL
Intervention: Hydrogel moist wound dressing (Elasto-gel)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Breast shells and lanolin cream
Number of subjects: 42
Study: 7658603

Group type: EXPERIMENTAL
Intervention: Soy oligosaccharide fiber (75 g/L)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Soy polysaccharide fiber (20 g/L)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Oat fiber (15 g/L)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fiber-free diet
Number of subjects: 13

Group type: COMPARATOR
Intervention: Self-selected diet
Number of subjects: 13
Study: 2704504

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (Premarin) + 5 mg medroxyprogesterone acetate (Provera)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 1.25 mg conjugated equine estrogen (Premarin) + 5 mg medroxyprogesterone acetate (Provera)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (Premarin) + placebo
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 1.25 mg conjugated equine estrogen (Premarin) + placebo
Number of subjects: 95
Study: 407817

Group type: EXPERIMENTAL
Intervention: Oral cromolyn therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31928314

Group type: EXPERIMENTAL
Intervention: WAIS-R Block Design subtest
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: WAIS-R Arithmetic subtest
Number of subjects: 183

Group type: COMPARATOR
Intervention: Existing norms for English-speakers
Number of subjects: 183
Study: 31321541

Group type: EXPERIMENTAL
Intervention: CGRP-targeted treatments
Number of subjects: 0
Study: 27761732

Group type: EXPERIMENTAL
Intervention: 400 mg vaginal progesterone suppository twice daily
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 10 mg oral dydrogesterone twice daily
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 10 mg oral dydrogesterone twice daily combined with 0.1 mg GnRH‐α
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 10 mg oral dydrogesterone twice daily combined with 1500 IU hCG
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 400
Study: 25345840

Group type: EXPERIMENTAL
Intervention: Intralesional bevacizumab with antiretroviral therapy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Antiretroviral therapy alone (Control)
Number of subjects: 14
Study: 23539110

Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA) dosing strategy
Number of subjects: 38
Study: 21594828

Group type: EXPERIMENTAL
Intervention: Heparin administration (Hep [+])
Number of subjects: 480

Group type: COMPARATOR
Intervention: No heparin administration (Hep [‐])
Number of subjects: 480
Study: 19155456

Group type: EXPERIMENTAL
Intervention: Escitalopram (10 to 20 mg/d for 12 weeks)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 16487841

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo-Inspiratory Muscle Training (P-IMT)
Number of subjects: 32
Study: 15250844

Group type: EXPERIMENTAL
Intervention: 2‐D PSMA (life size picture of tennis and golf balls)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 3‐D PSMAs (tennis and golf balls)
Number of subjects: 113

Group type: COMPARATOR
Intervention: None (Control for Food Set 1 and Food Set 3)
Number of subjects: 113
Study: 11277342

Group type: EXPERIMENTAL
Intervention: ACE inhibitor therapy (enalapril maleate, imidapril hydrochloride, trandolapril)
Number of subjects: 75
Study: 9309743

Group type: COMPARATOR
Intervention: SVC position (n = 10, group A)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Left subclavian vein position (n = 7, group B)
Number of subjects: 17
Study: 7901049

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terbutaline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tulobuterol
Number of subjects: 0
Study: 3518855

Group type: EXPERIMENTAL
Intervention: EEA stapling gun
Number of subjects: 100

Group type: COMPARATOR
Intervention: Hand suture using a single layer of interrupted sutures
Number of subjects: 100
Study: 31164313

Group type: EXPERIMENTAL
Intervention: A + FMS intervention
Number of subjects: 282

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 282
Study: 27743129

Group type: EXPERIMENTAL
Intervention: 4-h Oral Fat Tolerance Test (OFTT) without prior exercise
Number of subjects: 21

Group type: COMPARATOR
Intervention: 4-h Oral Fat Tolerance Test (OFTT) with 1-h prior aerobic exercise
Number of subjects: 21
Study: 27093772

Group type: EXPERIMENTAL
Intervention: Oral-B 3D White Radiant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive Control (PC) manual brush
Number of subjects: 0
Study: 25300874

Group type: EXPERIMENTAL
Intervention: Multicomponent online sleep intervention (sleep information, sleep hygiene education, cognitive behavioral therapy)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standardized cardiovascular risk factor and lifestyle-education session (usual care)
Number of subjects: 134
Study: 22042636

Group type: EXPERIMENTAL
Intervention: Plasma total omega-3
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: EPA (0.1 unit)
Number of subjects: 109
Study: 20603300

Group type: EXPERIMENTAL
Intervention: Live music
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control/reading group
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Participants with increased depressive symptoms
Number of subjects: 47
Study: 17576075

Group type: EXPERIMENTAL
Intervention: Hypnotic induction by audiotape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypnotic induction live
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test-retest design
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subjective experiences and expectancies
Number of subjects: 0
Study: 15920041

Group type: EXPERIMENTAL
Intervention: Intermittent high-intensity exercise (IHE)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Moderate-intensity exercise (MOD)
Number of subjects: 7
Study: 12855079

Group type: EXPERIMENTAL
Intervention: VR-delivered exercise program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional exercise program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VR exercise program
Number of subjects: 0
Study: 11847803

Group type: EXPERIMENTAL
Intervention: Exercise program
Number of subjects: 104

Group type: COMPARATOR
Intervention: No-exercise
Number of subjects: 104
Study: 9346976

Group type: EXPERIMENTAL
Intervention: DTaP
Number of subjects: 1293

Group type: COMPARATOR
Intervention: DTwP
Number of subjects: 1293
Study: 8416406

Group type: EXPERIMENTAL
Intervention: Full-strength acellular pertussis vaccine (40 micrograms of pertussis proteins)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Half-strength acellular pertussis vaccine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Quarter-strength acellular pertussis vaccine
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard adult tetanus-diphtheria vaccine alone
Number of subjects: 118
Study: 3816923

Group type: EXPERIMENTAL
Intervention: 8 mg controlled release (CR) tablets of salbutamol b.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: 4 mg conventional tablets of salbutamol a.i.d.
Number of subjects: 20
Study: 31961494

Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31975122

Group type: EXPERIMENTAL
Intervention: VEPTR surgery with administration of preoperative antibiotics more than 30 minutes before surgery (or >60 minutes for vancomycin)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: VEPTR surgery with intraoperative temperature less than 35.0°C
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: VEPTR surgery with assisted feeding
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: VEPTR surgery in male patients
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: VEPTR implant surgeries
Number of subjects: 22
Study: 29901949

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 52
Study: 25049137

Group type: EXPERIMENTAL
Intervention: Motivational intervention followed by self-regulatory intervention
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Self-regulatory intervention followed by motivational intervention
Number of subjects: 205
Study: 23326138

Group type: EXPERIMENTAL
Intervention: Laparoscopic TME (LTME)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Open TME (OTME)
Number of subjects: 138
Study: 20005697

Group type: EXPERIMENTAL
Intervention: Docetaxel (D) with prednisone
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Mitoxantrone (M) with prednisone
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: Risk groups classification
Number of subjects: 1006
Study: 18434214

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation protocol
Number of subjects: 62

Group type: COMPARATOR
Intervention: Traditional rehabilitation protocol
Number of subjects: 62
Study: 16650578

Group type: EXPERIMENTAL
Intervention: alpha2M Val1000Ile polymorphism
Number of subjects: 551

Group type: COMPARATOR
Intervention: Control group (no polymorphism)
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: alpha2M, LRP, RAP polymorphisms
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: alpha2M Val1000Ile allele frequencies
Number of subjects: 551

Group type: EXPERIMENTAL
Intervention: LRP and RAP polymorphisms
Number of subjects: 551
Study: 14518525

Group type: EXPERIMENTAL
Intervention: BOLD-fMRI
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: NIRS
Number of subjects: 22
Study: 10657270

Group type: EXPERIMENTAL
Intervention: Inhaled carbon dioxide (CO2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voluntary hyperventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Supplementary oxygen (6 litres/min)
Number of subjects: 0
Study: 8866596

Group type: EXPERIMENTAL
Intervention: Salmeterol dry powder, 50 microg b.i.d. via a Diskhaler (n=92)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Dose‐titrated slow‐release theophylline capsules ('Theo‐Dur') b.i.d. (n=97)
Number of subjects: 189
Study: 29861050

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT) with normal PTF‐V1
Number of subjects: 941

Group type: COMPARATOR
Intervention: Cardiac Resynchronization Therapy (CRT) with abnormal PTF‐V1
Number of subjects: 941
Study: 26562186

Group type: EXPERIMENTAL
Intervention: PGX softgel
Number of subjects: 14

Group type: COMPARATOR
Intervention: Rice flour softgel (control)
Number of subjects: 14
Study: 25184941

Group type: EXPERIMENTAL
Intervention: Swiss Diagnosis Related Groups (SwissDRG)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Before SwissDRG
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: After SwissDRG
Number of subjects: 395
Study: 22972753

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Fibromyalgia education (FE)
Number of subjects: 114
Study: 21168637

Group type: EXPERIMENTAL
Intervention: Emergency direct portacaval shunt (EPCS)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Endoscopic sclerotherapy (EST)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Unrandomized portacaval shunt (PCS)
Number of subjects: 211
Study: 17656473

Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements with IDPN
Number of subjects: 186

Group type: COMPARATOR
Intervention: Oral nutritional supplements without IDPN
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Both groups (with and without IDPN)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Increase in prealbumin >30 mg/L within 3 months
Number of subjects: 186
Study: 16273458

Group type: EXPERIMENTAL
Intervention: Motor conduction study (ulnar, peroneal nerve)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: F wave examination
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sensory conduction study (ulnar, sural nerve)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sympathetic skin response (SSR)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Heart rate variability test at rest
Number of subjects: 19
Study: 11870174

Group type: EXPERIMENTAL
Intervention: High-dose adjuvant interferon alfa-2b (IFNα2b)
Number of subjects: 0
Study: 10192568

Group type: EXPERIMENTAL
Intervention: Drain removed on postoperative day 3
Number of subjects: 90

Group type: COMPARATOR
Intervention: Drain kept until discharge had decreased to less than 35 ml/24 hours
Number of subjects: 90
Study: 7491817

Group type: EXPERIMENTAL
Intervention: PFP vaccine
Number of subjects: 47

Group type: COMPARATOR
Intervention: TIV vaccine (control)
Number of subjects: 47
Study: 2176794

Group type: EXPERIMENTAL
Intervention: 2% lidocaine hydrochloride
Number of subjects: 24

Group type: COMPARATOR
Intervention: pH-adjusted 1.73% lidocaine (1 ml of NaHCO3 44.6 meq/L added to 10 ml of 2% lidocaine hydrochloride)
Number of subjects: 24
Study: 529340

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (800 or 1600 IU) for 9 weeks or more
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31831203

Group type: EXPERIMENTAL
Intervention: add-on ramelteon
Number of subjects: 120

Group type: COMPARATOR
Intervention: haloperidol/risperidone
Number of subjects: 120
Study: 30696266

Group type: EXPERIMENTAL
Intervention: Lip repair at 6 months and palate repair at 4 years
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Neonatal lip repair and palate repair at 9 months
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Lip repair at 3 months and palate repair at 9 months
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (13 plaster casts of 8-year-old boys without UCLP)
Number of subjects: 64
Study: 27380034

Group type: EXPERIMENTAL
Intervention: Monobloc appliance
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Bibloc appliance
Number of subjects: 165

Group type: COMPARATOR
Intervention: Cost of treatment
Number of subjects: 165
Study: 25308625

Group type: EXPERIMENTAL
Intervention: Self-monitoring of blood glucose
Number of subjects: 292

Group type: COMPARATOR
Intervention: Self-monitoring of urine glucose
Number of subjects: 292
Study: 23672972

Group type: EXPERIMENTAL
Intervention: Bicanalicular silicone intubation for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: No silicone intubation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Bicanalicular silicone intubation
Number of subjects: 120
Study: 21356042

Group type: EXPERIMENTAL
Intervention: Percutaneous closure of PFO using the Amplatzer PFO Occluder
Number of subjects: 414

Group type: COMPARATOR
Intervention: Best medical treatment (warfarin for 6 months followed by antiplatelet agents)
Number of subjects: 414
Study: 19416245

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 73

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 73
Study: 16194588

Group type: EXPERIMENTAL
Intervention: Achilles tendon rupture patients (3 subjects)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Healthy control subjects (8 subjects)
Number of subjects: 11
Study: 15672950

Group type: EXPERIMENTAL
Intervention: Inhouse made (IHM) embryo culture medium
Number of subjects: 100

Group type: COMPARATOR
Intervention: Commercial Cook Sydney IVF Cleavage medium (SIC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Clinical pregnancy rate per transfer
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Implantation rate
Number of subjects: 100